Naive and TLR4 Stimulated Adipose Derived Mesenchymal Stem Cells Inhibit EMT and Metastasis of Pancreatic Ductal Adenocarcinoma Cells


Kaçaroğlu D., Yaylacı S., Gürbüz N.

3. International Multidisciplinary Cancer Research Congress, İstanbul, Türkiye, 7 - 10 Eylül 2023, ss.69

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: İstanbul
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.69
  • Lokman Hekim Üniversitesi Adresli: Evet

Özet

Introduction: In order to intervene in the dense desmoplastic tumor microenvironment, it is important to first elucidate the interactions between cells. To investigate the potential antitumorigenic effects of adipose-derived MSC(ADMSC) on the pancreatic ductal epithelial cell Panc-1, we aimed to investigate the effects of both proinflammatory and anti-inflammatory ADMSC phenotypes on EMT and metastasis.

Material and method: ADMSCs were treated with TLR4 agonist and antagonist. Pro-inflammatory and anti-inflammatory characters were determined according to their responses to cytokines. An indirect co-culture model was established using 0.4 µm inserts and Panc-1 and ADMSCs were cultured at a ratio of 1:10. Next, gene expression levels of CDH1, VIM, ZEB1 and CLDN1 were evaluated  for EMT analysis. Analysis of vimentin and E cadherin proteins was also evaluated by immunofluorescence staining. Metastatic potential was also analyzed by gene expressions of MMP2, KDR, PLAU, MMP9, TIMP1, IGF2R and COL1A1.

Results: At the end of the 96h, naive and proinflammatory ADMSCs increased the expression of CDH1 and CLDN1 of Panc-1 cells and decreased the expression of VIM gene. In metastasis related genes, it significantly decreased the expression of MMP2, KDR, MMP9, TIMP1, IGF2R and COL1A1 genes, except for the PLAU gene. ADMSCs with anti-inflammatory character, showed opposite effects.

Conclusion: Both naive ADMSCs and proinflammatory ADMSCs were showed antitumor effects on Panc-1 cells. Anti-inflammatory ADMSCs were showed tumor promoting effects. Understanding the role of MSCs in the tumor microenvironment will be a guiding factor for the development of microenvironment-targeted therapeutic approaches in the future.

Keywords: Pancreatic cancer, Mesenchymal stem cell, TLR4, Tumor microenvironment.